Pediatric Cancer Research Foundation Grants support researchers pursuing childhood cancer studies, training, and clinical applications to bring better treatments to children sooner and improve outcomes.
Funder: Pediatric Cancer Research Foundation
Due Dates (Anticipated): April 2027 (Letter of Intent) | July 2027 (Full application)
Funding Amounts: Emerging Investigator: up to $75,000 for one year; Translational: up to $100,000/year for two years; Legacy basic science: up to $150,000/year for three years
Summary: Supports pediatric cancer research that advances promising treatments and improves outcomes for children with cancer.
Key Information: Principal investigators must work at a U.S. nonprofit institution affiliated with a hospital.
The Pediatric Cancer Research Foundation (PCRF) funds childhood cancer research aimed at bringing promising, life-saving treatments to children sooner. Working directly with doctors, researchers, and nurses, the foundation identifies obstacles to developing treatments and caring for children with cancer. Its priorities are Powering Research, Equitable Care, and Survivorship & Mental Health.
PCRF emphasizes more effective therapies with fewer short- and long-term side effects, AI and advanced technologies that accelerate discovery, clinical trials, and research addressing disparities in care. The program includes Emerging Investigator Fellowship, Translational Research, Legacy Researcher, and Designated Grant categories. The 2026 solicitation supported Emerging Investigators exclusively; PCRF plans to reopen the full grant cycle in 2027, including Translational and Legacy Researcher grants and additional opportunities.